ARTES receives French Research Tax Credit (CIR) Accreditation

ARTES Biotech­nol­o­gy GmbH today announced that it has just obtained gov­ern­men­tal approval for ‘Crédit d’Impôt Recherche’ (CIR) for a three-year peri­od from the French Min­istry of High­er Edu­ca­tion and Research (MESR). The French R&D tax cred­it CIR gives French com­pa­nies the abil­i­ty to claim tax relief on 30% on all gen­er­at­ed costs out­sourced to ARTES’ […]

ARTES was part of a successful international consortium

EU Research Project Nano3Bio sums up: Promis­ing achieve­ments for win­ning future raw mate­ri­als Since fos­sil raw mate­ri­als are rapid­ly run­ning out, their sub­sti­tu­tion by renew­able resources is becom­ing increas­ing­ly impor­tant. In this process, the bio­log­i­cal pro­duc­tion of raw mate­ri­als will have to play a lead­ing role. The inter­na­tion­al project Nano3Bio, includ­ing ARTES Biotech­nol­o­gy has con­tributed […]

ARTES received next grant of patent for METAVAX®

ARTES is pleased to announce a new EU based grant of patent for their well-proven virus-like-par­ti­­­cle (VLP) tech­nol­o­gy plat­form METAVAX®. “The new patent inte­grates exact­ly in our exist­ing patent port­fo­lio and will fur­ther strength­en our tech­nol­o­gy offer”, said Dr. Melanie Pio­ntek, Busi­ness Devel­op­ment Direc­tor of ARTES. “In com­bi­na­tion with our pro­pri­etary yeast expres­sion tech­nol­o­gy our […]